鶹Ů

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 鶹Ů Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Oct 18 2021

Full Issue

J&J Vaccine Should Have Been 2 Shots All Along, Fauci And Others Say

Infectious-disease expert Dr. Anthony Fauci also acknowledged that some J&J recipients might be better off receiving Pfizer or Moderna’s vaccine as their booster. "The level of antibodies that you induce in them is much higher than if you boost them with the original J&J,” he said.

Dr. Anthony Fauci on Sunday said he believes Johnson & Johnson should’ve doled out a two-dose COVID-19 shot — as health experts recommend getting a booster to the one-shot jab as soon as it becomes available. The White House chief medical advisor said that the unanimous decision Friday by the Food and Drug Administration advisory panel to recommend the booster shots should be welcomed news for recipients of the vaccine. (Salo, 10/17)

The single-dose Johnson & Johnson vaccine that last week won approval from FDA advisers for a booster shot probably should have been a two-shot vaccine from the start, the nation's top infectious disease physician said Sunday. "What the advisers to the FDA felt is that, given the data that they saw, very likely this should have been a two-dose vaccine to begin with," Dr. Anthony Fauci told ABC's "This Week." The Food and Drug Administration vaccine advisory panel unanimously approved booster shots for the vaccine Friday for all J&J recipients 18 years and older – as early as two months after the first dose. (Bacon and Santucci, 10/17)

Over the last year, the Johnson & Johnson COVID-19 vaccine has been commonly referred to as a single-shot alternative to the two-dose regimens of mRNA vaccines from Pfizer-BioNTech and Moderna. But meeting Friday to consider whether to recommend approval of a booster dose for J&J's vaccine, an FDA advisory committee unanimously concluded that a second dose should be administered and suggested that the vaccine performs better as a two-dose series. (Dunleavy, 10/15)

In related news —

The optimistic turn in Covid-19 cases, hospitalizations and deaths could end in another spike in infections, Dr. Anthony Fauci said Sunday. But the US could still prevent that spike with higher vaccination rates. "If we don't do very well in that regard, there's always the danger that there will be enough circulating virus that you can have a stalling of the diminishing of the number of cases, and when that happens, as we've seen in the past with other waves that we've been through, there's the danger of resurgence," said Fauci, the director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to President Joe Biden, on Fox News Sunday. (Holcombe, 10/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 鶹Ů